AJOONI — Ajooni Biotech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapNeutral

Annual balance sheet for Ajooni Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	2.44	0.574	4.93	4.28	71
Net Total Accounts Receivable
Net Total Receivables	157	160	246	165	295
Total Inventory
Total Other Current Assets
Total Current Assets	214	219	347	323	620
Net Property, Plant And Equipment	51.6	62.1	65.5	112	112
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	280	290	587	475	951
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	105	101	152	30.1	48.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	124	126	171	48.1	69.7
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	157	164	417	427	881
Total Liabilities & Shareholders' Equity	280	290	587	475	951
Total Common Shares Outstanding